Gastroenteric neuroendocrine neoplasms classification: Comparison of prognostic models

Cancer

Volumn 119, Issue 1, 2013, Pages 36-44

  Dolcetta Capuzzo, Anna ^a   Villa, Valentina ^a   Albarello, Luca ^a   Franchi, Giulia M ^a   Gemma, Marco ^a   Scavini, Marina ^a   Di Palo, Saverio ^a   Orsenigo, Elena ^a   Bosi, Emanuele ^a   Doglioni, Claudio ^a   Manzoni, Marco F ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

classification; gastroenteric tract; neuroendocrine neoplasm; neuroendocrine tumors; prognosis; TNM; World Health Organization

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; FEMALE; GASTROENTERIC NEUROENDOCRINE NEOPLASM; HUMAN; INTERMETHOD COMPARISON; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; PATIENT CODING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ADULT; AGED; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASM GRADING; NEOPLASM STAGING; NEUROENDOCRINE TUMORS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84872826979     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27716     Document Type: Article

References (34)

1. Kloppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology. 2009; 90: 162-166.
2. Plockinger U, Rindi G, Arnold R, et al. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology. 2004; 80: 394-424.
3. Kloppel G, Perren A, Heitz PU,. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004; 1014: 13-27.
4. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006; 449: 395-401.
5. Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007; 451: 757-762.
6. Kloppel G,. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer. 2011; 18 (suppl 1): S1-S16.
7. Ramage JK, Ahmed A, Ardill J, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut. 2012; 61: 6-32.
8. Williams RA, Whitehead R,. Non-carcinoid epithelial tumours of the appendix-a proposed classification. Pathology. 1986; 18: 50-53.
9. Kloppel G,. Tumour biology and histopathology of neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab. 2007; 21: 15-31.
10. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
11. Bosman TF, Carniero F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010.
12. Rindi G, Wiedenmann B,. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol. 2011; 8: 54-64.
13. Pape UF, Jann H, Muller-Nordhorn J, et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008; 113: 256-265.
14. Ekeblad S, Skogseid B, Dunder K, Oberg K, Eriksson B,. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res. 2008; 14: 7798-7803.
15. Oberg K, Castellano D,. Current knowledge on diagnosis and staging of neuroendocrine tumors. Cancer Metastasis Rev. 2011; 30 (suppl 1): 3-7.
16. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008; 26: 3063-3072.
17. Fischer L, Kleeff J, Esposito I, et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg. 2008; 95: 627-635.
18. Lepage C, Rachet B, Coleman MP,. Survival from malignant digestive endocrine tumors in England and Wales: a population-based study. Gastroenterology. 2007; 132: 899-904.
19. Kloppel G, Rindi G, Anlauf M, Perren A, Komminoth P,. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch. 2007; 451 (suppl 1): S9-S27.
20. Scarpa A, Mantovani W, Capelli P, et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol. 2010; 23: 824-833.
21. Rindi G, de Herder WW, O'Toole D, Wiedenmann B,. Consensus guidelines for the management of patients with digestive neuroendocrine tumors: why such guidelines and how we went about It. Neuroendocrinology. 2006; 84: 155-157.
22. Arnold R, Chen YJ, Costa F, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation. Neuroendocrinology. 2009; 90: 227-233.
23. Falconi M, Bettini R, Scarpa A, Capelli P, Pederzoli P,. Surgical strategy in the treatment of gastrointestinal neuroendocrine tumours. Ann Oncol. 2001; 12 (suppl 2): S101-S103.
24. Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer. 2005; 12: 1083-1092.
25. Jann H, Roll S, Couvelard A, et al. Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer. 2011; 117: 3332-3341.
26. La Rosa S, Inzani F, Vanoli A, et al. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Hum Pathol. 2011; 42: 1373-1384.
27. Anlauf M, Garbrecht N, Bauersfeld J, et al. Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Arch. 2007; 451: 29-38.
28. Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15: 361-387.
29. Newson R,. Comparing the predictive power of survival models using Harrell's c or Somers' D. Stata J. 2010; 10: 339-358.
30. Rindi G, Azzoni C, La Rosa S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999; 116: 532-542.
31. Van Eeden S, Quaedvlieg PF, Taal BG, Offerhaus GJ, Lamers CB, Van Velthuysen ML,. Classification of low-grade neuroendocrine tumors of midgut and unknown origin. Hum Pathol. 2002; 33: 1126-1132.
32. Mullen JT, Wang H, Yao JC, et al. Carcinoid tumors of the duodenum. Surgery. 2005; 138: 971-977; discussion 977-978.
33. Weber HC, Venzon DJ, Lin JT, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 1995; 108: 1637-1649.
34. Kloppel G, Rindi G, Perren A, Komminoth P, Klimstra DS,. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch. 2010; 456: 595-597.